Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Pharmarise Holdings Corp. ( (JP:2796) ).
Pharmarise Holdings Corporation reported its consolidated financial results for the fiscal year ending May 31, 2025, showing a significant increase in net sales by 16.6% to 63,508 million yen. However, the company faced a decline in operating profit and ordinary profit, with a net loss attributable to owners of the parent company amounting to 367 million yen. The company’s financial position saw a decrease in net assets and equity ratio, while cash flows from operating activities decreased. The company also announced a reduction in dividends per share from 20 yen to 14 yen. Despite these challenges, Pharmarise Holdings forecasts a positive outlook for the next fiscal year, with expected growth in net sales and profits.
More about Pharmarise Holdings Corp.
Pharmarise Holdings Corporation is a company listed on the Tokyo Stock Exchange, primarily involved in the pharmaceutical industry. The company focuses on providing healthcare products and services, with a market focus on the Japanese healthcare sector.
Average Trading Volume: 29,773
Technical Sentiment Signal: Sell
Current Market Cap: Yen5.86B
See more data about 2796 stock on TipRanks’ Stock Analysis page.